tradingkey.logo

Exact Sciences Corp

EXAS
101.740USD
+0.240+0.24%
Close 12/15, 16:00ETQuotes delayed by 15 min
19.27BMarket Cap
LossP/E TTM

Exact Sciences Corp

101.740
+0.240+0.24%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Exact Sciences Corp

Currency: USD Updated: 2025-12-12

Key Insights

Exact Sciences Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 16/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 98.67.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Exact Sciences Corp's Score

Industry at a Glance

Industry Ranking
16 / 404
Overall Ranking
85 / 4592
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 23 analysts
Hold
Current Rating
98.673
Target Price
-2.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Exact Sciences Corp Highlights

StrengthsRisks
Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 32.37% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.76B.
Fairly Valued
The company’s latest PE is -19.01, at a medium 3-year percentile range.
Held by Invesco
Star Investor Invesco holds 176.61K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.52.

Financial Health

Currency: USD Updated: 2025-12-12

The current financial score of Exact Sciences Corp is 7.31, ranking 133/404 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 850.74M, representing a year-over-year increase of 20.05%, while its net profit experienced a year-over-year increase of 48.76%.

Score

Industry at a Glance

Previous score
7.31
Change
0

Financials

6.69

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

2.70

Operational Efficiency

10.00

Growth Potential

9.66

Shareholder Returns

7.52

Exact Sciences Corp's Company Valuation

Currency: USD Updated: 2025-12-12

The current valuation score of Exact Sciences Corp is 7.55, ranking 107/404 in the Biotechnology & Medical Research industry. Its current P/E ratio is -19.01, which is -61.60% below the recent high of -7.30 and -289.89% above the recent low of -74.11.

Score

Industry at a Glance

Previous score
7.55
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 16/404
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-12

The current earnings forecast score of Exact Sciences Corp is 6.43, ranking 341/404 in the Biotechnology & Medical Research industry. The average price target for Exact Sciences Corp is 105.00, with a high of 105.00 and a low of 68.11.

Score

Industry at a Glance

Previous score
6.43
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 23 analysts
Hold
Current Rating
98.673
Target Price
-2.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

534
Total
6
Median
6
Average
Company name
Ratings
Analysts
Exact Sciences Corp
EXAS
23
CRISPR Therapeutics AG
CRSP
30
argenx SE
ARGX
25
Intellia Therapeutics Inc
NTLA
25
IQVIA Holdings Inc
IQV
25
BeOne Medicines AG
ONC
24
1
2
3
...
107

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-12

The current price momentum score of Exact Sciences Corp is 9.77, ranking 3/404 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 113.77 and the support level at 77.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.76
Change
0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(1)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
-1.994
Neutral
RSI(14)
89.734
Overbought
STOCH(KDJ)(9,3,3)
62.320
Buy
ATR(14)
0.368
High Vlolatility
CCI(14)
165.229
Buy
Williams %R
21.000
Buy
TRIX(12,20)
1.553
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
101.420
Buy
MA10
101.270
Buy
MA20
97.168
Buy
MA50
77.034
Buy
MA100
63.314
Buy
MA200
56.634
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-12

The current institutional shareholding score of Exact Sciences Corp is 10.00, ranking 1/404 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 105.49%, representing a quarter-over-quarter decrease of 0.60%. The largest institutional shareholder is The Vanguard, holding a total of 17.76M shares, representing 9.36% of shares outstanding, with 0.54% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
17.87M
+1.73%
Capital World Investors
18.20M
+2.05%
Fidelity Management & Research Company LLC
23.28M
-3.53%
BlackRock Institutional Trust Company, N.A.
7.04M
-8.35%
Wellington Management Company, LLP
12.00M
-3.98%
State Street Investment Management (US)
5.38M
-18.67%
MFS Investment Management
2.96M
+97.24%
Geode Capital Management, L.L.C.
3.24M
-0.90%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-12

The current risk assessment score of Exact Sciences Corp is 8.76, ranking 4/404 in the Biotechnology & Medical Research industry. The company's beta value is 1.41. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.76
Change
0
Beta vs S&P 500 index
1.41
VaR
+5.03%
240-Day Maximum Drawdown
+31.11%
240-Day Volatility
+54.69%

Return

Best Daily Return
60 days
+23.68%
120 days
+23.68%
5 years
+26.77%
Worst Daily Return
60 days
-3.46%
120 days
-7.99%
5 years
-23.48%
Sharpe Ratio
60 days
+4.59
120 days
+2.93
5 years
+0.21

Risk Assessment

Maximum Drawdown
240 days
+31.11%
3 years
+59.30%
5 years
+78.21%
Return-to-Drawdown Ratio
240 days
+2.61
3 years
+0.28
5 years
-0.03
Skewness
240 days
+2.50
3 years
+1.10
5 years
+1.02

Volatility

Realised Volatility
240 days
+54.69%
5 years
+58.41%
Standardised True Range
240 days
+2.11%
5 years
+3.10%
Downside Risk-Adjusted Return
120 days
+635.85%
240 days
+635.85%
Maximum Daily Upside Volatility
60 days
+69.04%
Maximum Daily Downside Volatility
60 days
+39.02%

Liquidity

Average Turnover Rate
60 days
+1.61%
120 days
+1.56%
5 years
--
Turnover Deviation
20 days
+52.38%
60 days
+18.10%
120 days
+14.45%

Peer Comparison

Biotechnology & Medical Research
Exact Sciences Corp
Exact Sciences Corp
EXAS
8.08 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amicus Therapeutics Inc
Amicus Therapeutics Inc
FOLD
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ascendis Pharma A/S
Ascendis Pharma A/S
ASND
8.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc
BCRX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Krystal Biotech Inc
Krystal Biotech Inc
KRYS
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Charles River Laboratories International Inc
Charles River Laboratories International Inc
CRL
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Exact Sciences Corp?

The TradingKey Stock Score provides a comprehensive assessment of Exact Sciences Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Exact Sciences Corp’s performance and outlook.

How do we generate the financial health score of Exact Sciences Corp?

To generate the financial health score of Exact Sciences Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Exact Sciences Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Exact Sciences Corp.

How do we generate the company valuation score of Exact Sciences Corp?

To generate the company valuation score of Exact Sciences Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Exact Sciences Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Exact Sciences Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Exact Sciences Corp.

How do we generate the earnings forecast score of Exact Sciences Corp?

To calculate the earnings forecast score of Exact Sciences Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Exact Sciences Corp’s future.

How do we generate the price momentum score of Exact Sciences Corp?

When generating the price momentum score for Exact Sciences Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Exact Sciences Corp’s prices. A higher score indicates a more stable short-term price trend for Exact Sciences Corp.

How do we generate the institutional confidence score of Exact Sciences Corp?

To generate the institutional confidence score of Exact Sciences Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Exact Sciences Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Exact Sciences Corp.

How do we generate the risk management score of Exact Sciences Corp?

To assess the risk management score of Exact Sciences Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Exact Sciences Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Exact Sciences Corp.
KeyAI